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ABSTRACT
Background: Previous studies have reported cross-
reactivity between latex and grass allergens. Inhibition
studies have indicated cross-reactivity of IgE with latex
and grass pollen proteins. A panel consisting of a 
few recombinant allergens, namely rPhI p 1, rPhl p 2,
rPhl p 5 and profilin, was sufficient to diagnose grass
pollen allergy in patients allergic to grass pollen.
Methods: Serum samples from 528 consecutive 
outpatients with IgE antibodies towards at least one
allergen (IgE level > 0.35 kAU/L) were selected for this
retrospective study. Total and specific serum IgE to rPhl
p 1, rPhl p 2, rPhl p 5, rBet v 1, rBet v 2, latex, birch,
hazel, mugwort, wall pellitory, Dermatophagoides
pteronissinus, Alternaria tenuis, cat and apple were
measured by the immunoenzymatic capsulated hydro-
philic carrier polymer (CAP) FEIA system (Pharmacia &
Upjohn).
Results: Of 123 polysensitized patients with antilatex
Ig1E, 12 (9.76%) had symptoms after latex exposure.
Ten of 12 subjects monosensitized to latex had symp-
toms after latex exposure. Symptomatic patients had
higher IgE levels to latex than symptomless patients 
(P = 0.046). A higher prevalence of antilatex IgE was
seen in sera containing specific IgE to rPhl p 1, rPhl 
p 5 and rBet v 2. A good correlation (Spearman’s 
r = 0.52; P = 0.001) between high levels of antilatex
IgE and total serum IgE was found.
Conclusions: The findings of the present study may
support the concept that a high proportion of sera
containing IgE to rBet v 2, rPhl p 1 and rPhl p 5 simul-
taneously contain antilatex IgE. Therefore, patients
with specific IgE to these recombinant allergens with
no history of current latex exposure may need addi-
tional evaluation.
Key words: Bet v 1, Bet v 2, latex, Phl p 1, Phl p 2, Phl
p 5, recombinant allergen.
INTRODUCTION
Previous studies have reported cross-reactivity between
latex, ragweed and blue grass allergens.1,2 Merret et al.
have shown that the off-season prevalence of antigrass
IgE in unselected British blood donors was approximately
20%, while among the donors who were latex positive,
84% showed antigrass IgE.3 Moreover, IgE antibodies 
to recombinant pollen allergens Phl p 1, Phl p 2, Phl p 5
and Bet v 2 account for a high percentage of grass
pollen-specific IgE.4,5
The relevance of profilin in fruit and vegetable allergy,
as well as its possible relevance in latex allergic patients,
was demonstrated by Vallier et al.6
Several commercial latex antibody assays are available
for use in diagnosis. Unfortunately, in vitro latex-specific
IgE determinations are problematic with regards to sen-
sitivity and specificity of the tests. Commercial latex
extracts are total protein extracts with varying composi-
tions of allergenic and non-allergenic proteins and over 
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250 polypeptides have been reported from the crude
preparation.7–10
The purpose of the present study was to determine the
prevalence of detectable Hevea brasiliensis latex-specific
IgE in atopic patients. It was thought useful to perform a
simultaneous series of IgE tests specific to allergens to
which the sensitivity of the general allergic population is
well documented. Moreover, patients were divided into
17 groups depending on their sensitization pattern to
recombinant allergens (patient’s individual IgE: reactivity
profile) and we evaluated the allergens against which IgE
most frequently reacted in these groups.
METHODS
Serum samples from 528 consecutive outpatients 
(287 males, mean age 27.27 years, range 4–77 years;
241 females, mean age 30.21 years, range 5–80 years)
referred to the allergy unit during the period from January
1996 to March 2000 with a positive capsulated hydro-
philic carrier polymer (CAP) result of at least class I to 
at least one allergen (IgE level > 0.35 kAU/L) were
selected for this retrospective study. Of 528 atopic
patients, 423 (80.1%) had symptoms of asthma and/or
rhinitis, 24 (4.55%) suffered from rhinitis and dermatitis,
36 (6.82%) had chronic urticaria and rhinitis and 45
(8.52%) had chronic pruritus associated with allergic
rhinitis. All patients had a history of rhinitis and/or asthma
after allergen exposure and positive skin tests (wheal
diameter > 5 mm).
Total and specific serum IgE to rPhl p 1, rPhl p 2, rPhl 
p 5, rBet v 1 and rBet v 2, the major allergens of grass
and birch, latex (k82), birch (t3), hazelnut tree (t4),
mugwort (w6), wall pellitory (w21) Dermatophagoides
pteronissinus (d1), Alternaria tenuis (m6), cat (e1) and
apple (f49) were measured by the immunoenzymatic 
CAP FEIA system (Pharmacia & Upjohn Diagnostics). The
ImmunoCAP latex is a non-ammoniated product derived
Table 1 Median value of serum latex-specific IgE in two groups of sera obtained from patients with and without symptoms after
latex exposure
n Mean age (years) IgE (kUA/L) P
Symptomatic patients 12 38.88 3.94 (1.47–> 100) 0.046
Symptomless patients 111 28.37 1.18 (0.42–8.88) 0.028
Data for IgE show median values with the 25th–75th percentile range given in parentheses.
P values were determined by the Mann–Whitney U-test.
Table 2 Patient’s individual IgE reactivity profiles
Sensitization n (%) Phl p 1 Phl p 2 Phl p 5 Bet v 1 Bet v 2 Total IgE (kAU/L)
pattern
1 108 (20.45) N N N N N 171 (57–465)
2 80 (15.15) P P P N N 207 (74–541)
3 69 (13.07) P P P N P 339 (140–799)
4 42 (7.95) P P P P P 428 (290–723)
5 37 (7.01) P N N N N 296 (109–612)
6 34 (6.44) N N N P N 80 (40–109)
7 29 (5.49) P N P N N 141 (64–433)
8 23 (4.36) N N P N N 163 (50–345)
9 21 (3.98) P P P P N 209 (52–379)
10 16 (3.03) P P N N N 121 (56–411)
11 15 (2.84) P N N P N 254 (158–400)
12 15 (2.84) P N P P N 121 (93–123)
13 15 (2.84) P N P N P 135 (15–321)
14 12 (2.27) P N P P P 586 (260–808)
15 4 (0.76) N N P P N 85 (40–210)
16 4 (0.76) P N N N P 177 (81–165)
17 4 (0.76) P P N P N 124 (66–171)
Data for total IgE are presented as the geometric mean with 25th–75th percentile ranges given in parentheses.
N, negative; P, positive; n, number of patients.
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from latex collected in Thailand from H. brasiliensis. 
The molecular weights of the proteins cover the range
from < 10 to > 100 kDa.8
One hundred and eight atopic patients lacking specific
IgE to rPhl p 1, rPhl p 2, rPhl p 5, rBet v 1 and rBet v 2
were also evaluated. These patients are part of the total
528 patients. Six patients had specific IgE to g6 but not to
Phl p 1, rPhl p 2, rPhl p 5, Bet v 1 and Bet v 2 (1.42% of
subjects allergic to grass pollen).
Statistical analysis
The different data did not approach a normal distribution.
Results are expressed as median, geometric mean and
25th–75th percentile. The non-parametric Mann– Whitney
U-test was used to compare specific IgE to recombinant
allergens and natural extracts. Correlation between vari-
ables was assessed by Spearman’s correlation coefficient
(rho). Statistical analysis was performed with SPSS for
Windows. P < 0.05 was considered significant.
RESULTS
Of 123 polysensitized patients with antilatex IgE, 12
(9.76%) had symptoms after exposure to latex. Eight
patients (6.50%) had asthma and rhinitis, and four
(3.25%) had dermatitis and rhinococonjuctivitis. Ten
patients were monosensitized to latex and all had symp-
toms after latex exposure.
Symptomatic patients had higher lgE levels to latex
than symptomless patients (Table 1).
Table 2 shows different patient’s individual IgE reactiv-
ity profiles and total IgE found in the sera from 528 atopic
patients.
Although the overall prevalence in the entire group
containing antilatex IgE was 25.8% (n = 133), the
prevalence in the different IgE reactivity profile groups
differed considerably from this value, with the preva-
lence in sera from patients with sensitization pattern
numbers 3, 4, 13 and 14 (Table 3) being the greatest at
67–92%.
A higher prevalence of antilatex IgE was seen in sera
containing specific IgE to rPhl p 1, rPhl p 5 and rBet v 2.
As shown in Table 3, a good correlation (r = 0.52, 
P = 0.001) between high levels of antilatex IgE and total
serum IgE was found in patients with sensitization pattern
numbers 3 and 4. Patients with reactivity profiles numbers
2 and 14 (Tables 2,3) did not show a clear correlation
between antilatex IgE and total serum IgE.
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A higher prevalence of anti-apple IgE was seen in sera
containing specific IgE to rBet v 1 and rPhl p 1, a higher
prevalence of specific anti-olive tree IgE was found in
sera containing IgE to rPhl p 1, rPhl p 5 and rBet v 2, and
a higher prevalence of antimugwort IgE was observed in
sera containing IgE to rPhI p 1, rPhl p 5 and rBet v 2.
Other results are summarized in Table 3.
A good correlation (P = 0.001) was found between
rPhl p 1 and latex, olive and mugwort, rPhl p 2 and olive,
rPhl p 5 and olive and mugwort, rBet v 1 and apple, and
rBet v 2 and latex, timothy grass, birch, hazel and
mugwort. Other results are summarized in Table 4.
DISCUSSION
In the present study, we found that latex sensitizaton is
overrepresented among patients with IgE to rBet v 2,
rPhl p 1 and rPhl p 5. Subjects selected for IgE to rBet 
v 2, rPhl p 1 and rPhl p 5 may, as a group, have an
enhanced overall propensity to form IgE to different
environmental allergens. If true, this would make them
more likely than unselected subjects to exhibit total 
and specific IgE to any allergen source, including latex.
Thus, in the present study, the higher frequency of latex
sensitization among subjects with IgE to rBet v 2 is not
necessarily a function of molecular cross-reactivity, as
demonstrated in previous studies.6 In contrast, an excel-
lent correlation between IgE to Bet v 2 and latex (g6 
and t9) was found.
Moreover, in sera from patients with sensitization
pattern numbers 3, 4 and 14, in whom IgE levels to Bet 
v 2 were higher, the prevalence of sensitization to latex
was increased as well as total IgE. In contrast, subjects
with the number 13 sensitization pattern showed a high
prevalence of antilatex IgE and low levels of total IgE. Of
course, it is not obvious that the formation of several
groups of patients showing different IgE antibody reactiv-
ity combinations or the statistical analysis performed
serves the purpose of identifying serological associations
in the best way possible; nevertheless, if confirmed in
other studies, this approach may be useful for the practi-
cal allergologist. A number of proteins and peptides from
H. brasiliensis latex have been identified as reacting with
IgE-relevant antibodies from latex-sensitive patients.13–24
Crude antigens contain relevant and non-relevant
protein and their use may produce variable results and
interpretations. Several latex allergens have been cloned
and sequenced; others have been partially character-
ized.7,11–14,16–18,22,23
Some authors suggest that Hev h 1 and Hev b 3 are
major allergens for children with multiple congenital
anomalies.24,25 However, Hev b 2 and Hev b 4 are more
important for health-care workers with latex allergy.18
Hev b 5 is recognized by specific IgE in a majority of both
health-care workers and latex-allergic children.19 How-
ever, it is important to recognize that recombinant
proteins derived from sequences cloned from Hevea
plant material may not represent naturally expressed
proteins or proteins that are present in finished products,
Moreover, recent studies indicate that additional antigens
may be needed to reach the diagnostic accuracy
obtained with crude latex.26
Fuchs et al.12 reported that sera from certain individu-
als with latex allergy showed IgE reactivity with protein
bands of different molecular weights in western-blotted
latex milk and glove extracts, both containing common
IgE epitopes. Although preincubation with rBet v 1 and
rBet v 2 did not significantly inhibit IgE binding to latex
proteins, weed and, in particular, timothy grass extract
strongly inhibited IgE binding to latex allergen.9
To support our statement that the correlation between
rBet v 2 and latex is based on a possible profilin cross-
reactivity, IgE inhibition experiments should have been
performed; however, the present study is retrospective.
Earlier studies27 have shown latex-specific IgE in atopic
individuals, especially patients aged < 18 years, with no
history or recurrent latex exposure and no history of
adverse reactions to latex. The higher prevalence of pos-
itive sera among subjects aged < 18 years suggests that
children are more frequently exposed to allergens that
cross-react with latex. Indeed, we have found previously
that patients in the age group 0–20 years had higher IgE
levels to rBet v 2, rPhl p 1, rPhl p 2 and rPhl p 5 than sub-
jects in an older age group.28
Moreover, a grass allergen extract may induce immune
reactions against components not recognized before
treatment.29–31 This has to be taken into consideration
when grass extracts are used for immunotherapy. This
supports the concept of using defined allergens (mole-
cules) for a component-resolved immunotherapy.
Finally, we found that patients with symptoms after latex
exposure had higher levels of IgE to latex than symptom-
less subjects. This supports the findings of previous
reports.33
In conclusion, patients with specific IgE to rBet v 2, 
rPhl p 1 and rPhl p 5 and total high IgE levels, with no
history of recurrent latex exposure, may need additional
evaluation.
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